Literature DB >> 14963366

Mosquito allergy: immune mechanisms and recombinant salivary allergens.

Zhikang Peng1, F Estelle R Simons.   

Abstract

Reactions to mosquito bites are immunological in nature, with the involvement of IgE-, IgG- and T lymphocyte-mediated hypersensitivities. Acquired desensitization to mosquito saliva may occur during childhood and adolescence or during long-term exposure to mosquito bites. Due to the lack of salivary preparations, allergic reactions to mosquito bites are underdiagnosed and undertreated. Recombinant mosquito saliva allergens with biological activity are being developed. These recombinant allergens will significantly improve diagnosis of mosquito allergy and eventually will also improve specific immunotherapy for patients with systemic reactions to mosquito bites. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963366     DOI: 10.1159/000076787

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  29 in total

1.  Mosquito bites mimicking lesions on whole-body MRI for cancer staging in children.

Authors:  Henrique Manoel Lederman; Vivian Tostes; Jose Luiz de Oliveira Schiavon
Journal:  Pediatr Radiol       Date:  2017-12-01

Review 2.  [Frequent and rare dermatological diseases in HIV patients].

Authors:  U R Hengge; R Mota; A Marini
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

3.  Cloning, expression, and characterization of salivary apyrase from Aedes albopictus.

Authors:  Fang Dong; Yongfeng Fu; Xueping Li; Jianguo Jiang; Jianhua Sun; Xunjia Cheng
Journal:  Parasitol Res       Date:  2011-08-14       Impact factor: 2.289

4.  Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites.

Authors:  Souleymane Doucoure; François Mouchet; Amandine Cournil; Gilbert Le Goff; Sylvie Cornelie; Yelin Roca; Mabel Guerra Giraldez; Zaira Barja Simon; Roxanna Loayza; Dorothée Misse; Jorge Vargas Flores; Annie Walter; Christophe Rogier; Jean Pierre Herve; Franck Remoue
Journal:  Am J Trop Med Hyg       Date:  2012-07-30       Impact factor: 2.345

5.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

6.  Identification, expression and characterisation of a major salivary allergen (Cul s 1) of the biting midge Culicoides sonorensis relevant for summer eczema in horses.

Authors:  Kathrin F A Langner; Donald L Jarvis; Manfred Nimtz; Julia E Heselhaus; Linda E McHolland; Wolfgang Leibold; Barbara S Drolet
Journal:  Int J Parasitol       Date:  2008-07-26       Impact factor: 3.981

7.  Aedes aegypti salivary protein "aegyptin" co-inoculation modulates dengue virus infection in the vertebrate host.

Authors:  M K McCracken; R C Christofferson; B J Grasperge; E Calvo; D M Chisenhall; C N Mores
Journal:  Virology       Date:  2014-08-28       Impact factor: 3.616

Review 8.  Mosquito Saliva: The Hope for a Universal Arbovirus Vaccine?

Authors:  Jessica E Manning; David M Morens; Shaden Kamhawi; Jesus G Valenzuela; Matthew Memoli
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

9.  Human immunoglobulin G responses to Cimex lectularius L. saliva.

Authors:  Johnathan M Sheele; Brian Ferrari; Jerome Goddard; Danie Schlatzer; Kathleen C Lundberg; Katirina Guinto; Monica E Embers; Andrew B Young; Gale E Ridge; Giovanni Damiani; Thomas S McCormick
Journal:  Parasite Immunol       Date:  2020-06-22       Impact factor: 2.280

10.  Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon.

Authors:  Bruno Bezerril Andrade; Bruno Coelho Rocha; Antonio Reis-Filho; Luís Marcelo Aranha Camargo; Wanderli Pedro Tadei; Luciano Andrade Moreira; Aldina Barral; Manoel Barral-Netto
Journal:  Malar J       Date:  2009-06-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.